ÌÇÐÄvlog

[Skip to Navigation]
Sign In

October 2024 - July 1959

Decade

Year

Issue

July 2023, Vol 80, No. 7, Pages 656-754

Viewpoint

Overdose Detection Technologies—A New Frontier in Preventing Solitary Drug Overdose Deaths

Abstract Full Text
free access
JAMA Psychiatry. 2023;80(7):657-659. doi:10.1001/jamapsychiatry.2023.0546

This Viewpoint examines current opioid overdose detection technologies and their utility in detecting potential drug overdose episodes and preventing solitary overdose deaths in the US.

Addiction Medicine Physicians and Medicinal Cannabinoids

Abstract Full Text
JAMA Psychiatry. 2023;80(7):659-660. doi:10.1001/jamapsychiatry.2023.0731

This Viewpoint communicates the importance of clinicians, particularly addiction clinicians, to be educated about both harmful and beneficial effects of cannabis and related products before making therapeutic recommendations.

Viewing Psychiatric Epidemiology Within a Global Historical Framework to Shape Future Practice

Abstract Full Text
JAMA Psychiatry. 2023;80(7):661-662. doi:10.1001/jamapsychiatry.2023.0785

This Viewpoint discusses the benefits of rethinking the history of psychiatric epidemiology from a global perspective.

Global Mental Health Services and the Impact of Artificial Intelligence–Powered Large Language Models

Abstract Full Text
free access
JAMA Psychiatry. 2023;80(7):662-664. doi:10.1001/jamapsychiatry.2023.1253

This Viewpoint describes ways in which artificial intelligence–powered large language models may be used to improve the delivery of mental health services worldwide.

Original Investigation

Effect of an Emergency Department Process Improvement Package on Suicide Prevention: The ED-SAFE 2 Cluster Randomized Clinical Trial

Abstract Full Text
free access
JAMA Psychiatry. 2023;80(7):665-674. doi:10.1001/jamapsychiatry.2023.1304

This randomized clinical trial determines if an emergency department process improvement package, with a subfocus on improving the implementation of collaborative safety planning, reduces subsequent suicide-related behaviors.

Evaluation of the Risk Identification for Suicide and Enhanced Care Model in a Native American Community

Abstract Full Text
free access
JAMA Psychiatry. 2023;80(7):675-681. doi:10.1001/jamapsychiatry.2022.5068

This cohort study evaluates the association of use of a statistical model to evaluate suicide risk with improvements in evidence-based care and reductions in subsequent suicide-related behaviors in a Native American population.

Depression Associated With Hormonal Contraceptive Use as a Risk Indicator for Postpartum Depression

Abstract Full Text
open access
JAMA Psychiatry. 2023;80(7):682-689. doi:10.1001/jamapsychiatry.2023.0807

This cohort study investigates previous depression associated with hormonal contraceptive use and risk for postpartum depression in Danish first-time mothers.

Association Between Depression and Physical Conditions Requiring Hospitalization

Abstract Full Text
open access
JAMA Psychiatry. 2023;80(7):690-699. doi:10.1001/jamapsychiatry.2023.0777

This cohort study examines data from the UK Biobank and 2 Finnish cohorts to gauge the association between depression and an array of physical conditions requiring hospital treatment.

Association Between False Memories and Delusions in Alzheimer Disease

Abstract Full Text
free access
JAMA Psychiatry. 2023;80(7):700-709. doi:10.1001/jamapsychiatry.2023.1012

This cross-sectional study uses behavioral testing and volumetric neuroimaging data to examine the association between false memories and delusions among individuals in the Alzheimer Disease Neuroimaging Initiative cohort.

Assessment of Disruptive Life Events for Individuals Diagnosed With Schizophrenia or Bipolar I Disorder Using Data From a Consumer Credit Reporting Agency

Abstract Full Text
open access
JAMA Psychiatry. 2023;80(7):710-717. doi:10.1001/jamapsychiatry.2023.1179

This case-control study assesses disruptive life events of individuals with schizophrenia or bipolar I disorder using public consumer credit records in conjunction with electronic health record data.

A Traitlike Dimension of Subjective Memory Concern Over 30 Years Among Adult Male Twins

Abstract Full Text
free access
JAMA Psychiatry. 2023;80(7):718-727. doi:10.1001/jamapsychiatry.2023.1004

This cohort study evaluates the heritability of subjective memory concern and its association with certain genetic risk indicators.

Associations Between General and Specific Psychopathology Factors and 10-Year Clinically Relevant Outcomes in Adult Swedish Twins and Siblings

Abstract Full Text
open access
JAMA Psychiatry. 2023;80(7):728-737. doi:10.1001/jamapsychiatry.2023.1162

This cohort study evaluates the association between psychopathology factors and clinically relevant outcomes at 10 years among twins and siblings.

Brief Report

Associations Between Symptoms of Premenstrual Disorders and Polygenic Liability for Major Psychiatric Disorders

Abstract Full Text
JAMA Psychiatry. 2023;80(7):738-742. doi:10.1001/jamapsychiatry.2023.1137

This genetic association study assesses whether symptoms of premenstrual disorders are associated with the genetic liability for major psychiatric disorders, as indexed by polygenic risk scores.

Special Communication

Importance of Integrating Spiritual, Existential, Religious, and Theological Components in Psychedelic-Assisted Therapies

Abstract Full Text
has active quiz
JAMA Psychiatry. 2023;80(7):743-749. doi:10.1001/jamapsychiatry.2023.1554

This Special Communication argues for the integration of spiritual, existential, religious, and theological components within psychedelic-assisted therapy based on the prevalence and importance of relevant experiences in psychedelic-assisted therapy.

Research Letter

Trends in Illicit Ketamine Seizures in the US From 2017 to 2022

Abstract Full Text
free access
JAMA Psychiatry. 2023;80(7):750-751. doi:10.1001/jamapsychiatry.2023.1423

This cross-sectional study evaluates trends in the number and weight of illicit ketamine seizures in the US from 2017 to 2022.

Comment & Response

Potential Limitations for Assessing Adverse Posttraumatic Neuropsychiatric Sequelae With Wrist-Wearable Device and Self-report Survey

Abstract Full Text
JAMA Psychiatry. 2023;80(7):751-752. doi:10.1001/jamapsychiatry.2023.1144

Potential Limitations for Assessing Adverse Posttraumatic Neuropsychiatric Sequelae With Wrist-Wearable Device and Self-report Survey—Reply

Abstract Full Text
JAMA Psychiatry. 2023;80(7):752. doi:10.1001/jamapsychiatry.2023.1147

Considerations Regarding Antipsychotic Drug Prescriptions Among People With Dementia During the COVID-19 Pandemic

Abstract Full Text
free access
JAMA Psychiatry. 2023;80(7):752-753. doi:10.1001/jamapsychiatry.2023.1247

Considerations Regarding Antipsychotic Drug Prescriptions Among People With Dementia During the COVID-19 Pandemic—Reply

Abstract Full Text
free access
JAMA Psychiatry. 2023;80(7):753-754. doi:10.1001/jamapsychiatry.2023.1250
Correction

Error in Table

Abstract Full Text
free access
JAMA Psychiatry. 2023;80(7):754. doi:10.1001/jamapsychiatry.2023.2469

Error in Byline

Abstract Full Text
free access
JAMA Psychiatry. 2023;80(7):754. doi:10.1001/jamapsychiatry.2023.1466

Errors in Figure 4

Abstract Full Text
free access
JAMA Psychiatry. 2023;80(7):754. doi:10.1001/jamapsychiatry.2023.1607
JAMA Psychiatry Masthead

JAMA Psychiatry

Abstract Full Text
free access
JAMA Psychiatry. 2023;80(7):656. doi:10.1001/jamapsychiatry.2022.3228
×